Image

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Description

Our overarching goal is to promote safe medication use/adherence for high-risk infants, by leveraging health literacy approaches and mobile technology to reinforce provider counseling and support parent medication management after discharge from the NICU. We will adapt/integrate evidence-based strategies studied in less complex populations, for this vulnerable group. The HELPix (Health Education and Literacy for Parents) pictogram-based intervention, developed by our team, incorporates these strategies, with sizeable improvements found in medication knowledge, dosing errors, and adherence in outpatient general pediatric settings, but to date, HELPix has not been studied in NICU settings

Eligibility

Inclusion Criteria:

  1. English or Spanish-speaking
  2. 18 years of age and older
  3. Child discharged home with a Rx for >1 daily liquid medication (other than multivitamin)
  4. Primary person who will administers child's medications.
  5. Willingness and ability to participate

Exclusion Criteria:

  1. Does not have a working phone number
  2. Does not have access to internet (via computer/smartphone)
  3. Does not have a mobile phone that receives texts.
  4. Not able to return to the hospital for their child's follow-up visit
  5. Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
  6. Uncorrectable hearing impairment

Study details

Medication Administered in Error

NCT04278690

NYU Langone Health

27 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.